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Abstract
Background: Intensive combined lifestyle interventions are the recommended treatment for severely obese
children and adolescents, but there is a lack of studies and their cost-effectiveness. The objective of this study is to
compare the cost-effectiveness of two intensive one-year inpatient treatments and usual care for severely obese
children and adolescents.
Methods/Design: Participants are 40 children aged 8-13 and 40 adolescents aged 13-18 with severe obesity
(SDS-BMI ≥ 3.0 or SDS-BMI ≥ 2.3 with obesity related co-morbidity). They will be randomized into two groups
that will receive a comprehensive treatment program of 12 months that focuses on nutrition, physical activity
and behavior change of the participant and their parents. The two programs are the same in total duration
(12 months), but differ in inpatient treatment duration. Group A will participate in a 6 month intensive inpatient
treatment program during weekdays, followed by six monthly return visits of 2 days. Group B will participate in
a 2 month intensive inpatient treatment program during weekdays, followed by biweekly return visits of 2 days
during the next four months, followed by six monthly return visits of 2 days. Several different health care
professionals are involved, such as pediatricians, dieticians, psychologists, social workers, nurses and
physiotherapists. Results will also be compared to a control group that receives usual care. The primary
outcome is SDS-BMI. Secondary outcomes include quality of life using the EQ-5D and cardiovascular risk factors.
Data will be collected at baseline and after 6, 12 and 24 months. An economic evaluation will be conducted
alongside this study. Healthcare consumption will be based on actual resource use, using prospective data
collection during 2 years through cost diaries. Quality Adjusted Life Years (QALYs) will be calculated using
the EQ-5D.
Discussion: This study will provide useful information on the effectiveness and cost-effectiveness of inpatient
treatment in severely obese children and adolescents. Valuable information on long term effects, after 2 years, is
also included.
Trial registration: Netherlands Trial Register (NTR): NTR1678
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Background
In the Netherlands the prevalence of obesity in children
and adolescents has increased during the last decades
[1-3]. Generally, when an increase in prevalence is
observed, there is a skewed distribution to the right
instead of a normal distribution, which means that a
disproportional large increase in the prevalence of severe
obesity is observed [4]. The prevalence of obesity in
children aged 4-15 years has increased from 0.2 to 2.6%
in boys and from 0.5 to 3.3% in girls in the period 1980-
2003 [3]. These trends are worrisome because obesity in
children is associated with an increased risk of several
chronic diseases such as diabetes type 2 and cardiovas-
cular diseases and musculoskeletal, respiratory and psy-
chosocial problems [5,6]. Obesity also tracks from
childhood into adulthood and is predictive for signifi-
cant health consequences in later life independent of
adult BMI [7-9]. Besides having an adverse impact on
healthy life years and quality of life, childhood obesity
also has a substantial impact on health care utilization
and results in a heavy financial burden for society
[10,11]. Although many programs for the treatment of
obesity exist, results have not been very promising, espe-
cially regarding their long term effectiveness. Neverthe-
less, a recent systematic review of inpatient programs
for children showed greater reductions in the percentage
overweight participants at post treatment and at follow-
up compared with results from a recent meta-analysis of
out-patient treatments [12]. Studies evaluating the effec-
tiveness of treatment programs (with or without an
inpatient period) aimed at children with severe obesity
are relatively rare [12,13]. However, it has been sug-
gested that ambulatory programs for severely obese chil-
dren and adolescents are insufficiently effective and that
there is a need for experienced, specialized pediatric
obesity centers for intensive treatment by professionals
with expertise in pediatric and adolescent medicine
[14,15]. Spear et al. describe the need for comprehensive
treatments that should be provided by multidisciplinary
obesity care teams, including for example social workers,
psychologists, dieticians, and exercise specialists [16].
The ideal approach in such comprehensive treatments
would include dietary modification, an increase in physi-
cal activity, a reduction in sedentary activity and beha-
vior modification [17,18]. A promising alternative for
ambulatory care is inpatient treatment in specialized
centers as mentioned above [12]. Heideheuvel (part of
Merem Treatment Centers) is the only specialized clinic
in the Netherlands offering an intensive combined life-
style inpatient intervention, focusing on nutrition, physi-
cal activity and behavior change of the participants and
their parents. This lifestyle intervention has a duration
of 12 months, with a 6 month inpatient period and is
designed for severely obese children and adolescents
between 8 and 18 years. However such a lengthy inpati-
ent treatment program involves high costs and a consid-
erable burden for both the child and the family.
Therefore, a new intensive combined lifestyle interven-
tion also with a duration of 12 months, but with a
shorter inpatient period (2 months) was developed at
Heideheuvel with the aim of being equally effective but
less costly and disturbing for family life.
The objective of this study is to compare the cost-
effectiveness of these two intensive one-year inpatient
treatments to each other and to usual care for severely
obese children and adolescents.
Methods/Design
Design
This study is designed as a randomized controlled clini-
cal trial with three study arms. The cost-effectiveness of
two intensive one-year treatments that vary in inpatient
period length and usual care for severely obese children
and adolescents will be evaluated. There is a one year
follow-up after treatment. Participants who meet the
inclusion criteria and consent to participate in the study
will be randomized to one of the three study arms
(described under ‘interventions’). Because of the nature
of the treatments evaluated in this study, parents and
participants as well as professionals at Heideheuvel and
in the usual care condition cannot be blinded to the
type of intervention. A table of random numbers is used
to randomize participants. At the beginning of the first
year 40 (13-18 years) participants are randomized into:
group A (10), group B (10) or group C (20). The partici-
pants in group C will be randomized into group A (10)
or B (10) after one year of receiving usual care. This
process is repeated for another 40 participants (8-13
years) after 6 months. At the end of the fourth year all
80 participants (40 in each inpatient treatment group)
will have completed the program and 1 year of follow
up (Figure 1). Data collection started in August 2009
and will continue until July 2013. The Medical Ethics
committee (METc) of VU University Medical Centre
approved the study design, protocol and informed con-
sent procedures.
Participants
The study population consists of children and adoles-
cents aged 8-18 years referred to Heideheuvel by their
own pediatrician. Pediatricians working at Heideheuvel
screen the referred participants for eligibility to be
included in the treatment. They must have a SDS-BMI
≥ 2.3 according to the growth curves based on the
fourth Dutch National Growth Study of 1997 (this cor-
responds to the 99th percentile) and co-morbidity
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related to obesity (e.g. obstructive sleep apnea syndrome,
raised insulin, diabetes type II, liver function disorders,
dyslipidemia, worn out joints) or a SDS-BMI ≥ 3.0 (this
corresponds to the 99.9th percentile). Participants will
be excluded if they have syndromal or chromosomal
determined obesity, obesity caused by endocrine disor-
ders (hypothyroidism, Cushing syndrome, primary
hyperinsulinemia, pseudohypoparathyroidism, acquired
(structural) hypothalamic damage) or medicine use (e.g.
oral steroids, antiepileptic drugs, antidepressants), severe
psychiatric problems, an IQ below 75 or similar school
level or if their parents are not willing to participate in
the treatment. Written informed consents are obtained
from both the participants and their parents.
Interventions
The intensive combined lifestyle interventions focus on
nutrition, physical activity and behavior change of the
participants and their parents. Many disciplines are
involved, such as pediatricians, dieticians, psychologists,
social workers, nurses, physiotherapists, general exercise
therapists and exercise therapists Cesar (a specific type
of exercise therapy in The Netherlands that is mainly
focused on posture, balance and coordination). Addi-
tional individual meetings with a psychologist, dietician
or social worker are offered if participants, parents or
professionals indicate that this is needed. During the
inpatient period, children and adolescents will partici-
pate in an exercise program four times a week and
nutrition education/behavior modification sessions once
per week. Behavior modification topics include self-reg-
ulation, self-awareness, goal setting, stimulus control,
coping skills training, cognitive behavior strategies and
contingency management. Behavior modification is
achieved through the ‘5 steps of problem solving’-plan.
The first step is to define the problem and learn to
describe it. The second step is to search for possible
solutions for the defined problem. Step 3 is to make an
inventory of the possible consequences for each possible
solution described in the second step. The fourth step is
to choose the best solution from the possible solutions.
The last step then is to implement this solution and to
evaluate this afterwards. If the problem is not solved,
one can go back to the first step. The nutritional educa-
tion component of the program will use an approach
not primarily aimed at caloric restriction but rather at
structured eating and healthier choices, focusing on
improving the quality of the dietary intake, and on try-
ing to establish a flexible control of eating behavior.
During the weekends at home in the inpatient period
the participants and their parents are required to
accomplish exercises regarding nutrition and physical
activity. During the period when the children are home
again the learned behavior is practiced at all times.
Group A will participate in a 6 months intensive inpa-
tient treatment program during weekdays, followed by
six monthly return visits of 2 days. Group B will partici-
pate in a 2 month intensive inpatient treatment program
during weekdays, followed by biweekly return visits of 2
days during the next four months, then followed by six
monthly return visits of 2 days. During the inpatient
treatment phase and the 2-day return visits all children
and adolescents stay overnight at Heideheuvel. Parents
of participants in groups A and B will attend 1 session
every week during the inpatient period and after that 1
session per return visit of their child. Group C will
receive usual care during one year, after which the parti-
cipants will be randomly allocated to the groups A and
B. This implies that during this year they remain under
the care of their pediatrician and other health care pro-
fessionals that might be involved in their treatment like
the general practitioner, dietician, physiotherapist and
psychologist.
Detailed descriptions of treatments A and B
Treatment A already existed before the start of the
study. Treatment B is based on treatment A, but
includes a shorter inpatient period in the first half year
to reduce the burden for parents and children. This
expands the opportunity for implementation of the
learned behavior at home. Treatment B also focuses
more on involvement of the parents from the beginning.
The focus of both treatments is on knowledge and
skills and implementation. In both treatments the same
topics are covered during the educational sessions, but
the form in which the education is given is slightly dif-
ferent (guidance by a psychologist, dietician or exercise
therapist in treatment A and by group coaches in treat-
ment B).
Both treatment A and B are divided into 4 phases: 1.
assessment/knowledge acquisition phase (week 1-6/1-8),
2. Knowledge acquisition and skills building phase (week
N = 10
Inpatient
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N = 10
Inpatient
Group B
N = 10
Inpatient
Group A
N = 10
Inpatient
Group B
N = 10
Inpatient
Group A
N = 10
Inpatient
Group B
N = 10
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N = 10
Inpatient
Group B
N = 40
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N = 40
Children 8-13
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Group
N = 20
Usual care
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Children 13-19
Figure 1 Flow chart of participants.
Makkes et al. BMC Public Health 2011, 11:518
http://www.biomedcentral.com/1471-2458/11/518
Page 3 of 9
7-18/9-18), 3. Implementation phase (week 19-26) and
4. Maintenance phase (27-52).
Phase 1 (weeks 1-6 for treatment A, weeks 1-8 for
treatment B)
During the first phase extensive physical and psychosocial
examinations are carried out. The children are medically
examined and they have several individual appointments
with among others the dietician and psychologist, both
with and without their parents, to assess what the problem
areas are for each child. During this period the children
receive schooling at a study centre at Heideheuvel, except
for the primary school children. They go to primary
schools in the neighborhood where the teachers can moni-
tor dietary habits of the children. A very important sec-
ondary goal in this phase is also the group formation.
Phase 2 (weeks 7-18 for treatment A, weeks 9-18 for
treatment B)
In the second phase, there are weekly (group A) or
biweekly (group B after the inpatient period) educational
group sessions for the children with a psychologist cov-
ering different topics, such as dealing with emotions,
self confidence and self image. During this period, the
children of treatment A go to a school in the vicinity of
Heideheuvel. Children of treatment B continue to
receive schooling at a study centre at Heideheuvel dur-
ing the inpatient period and the biweekly return visits,
when they are home they go back to the school in their
own neighborhood.
Phase 3 (weeks 19-26 for treatment A as well as for
treatment B)
In the third phase, the knowledge acquired in the pre-
vious phases is put into practice. In weeks 19 and 20
the children of group A have the last sessions of the
weekly education program supervised by a psychologist
and group coach. The children of group B will have
their last session in the last biweekly return visit. From
week 20 on in group A, one weekly visit to a movement
therapist can be exchanged for a visit to a sports centre
in the vicinity of the clinic, if the children like to per-
form sports not possible at the clinic. The children of
group B continue to do exercise during their biweekly
return visit. During phase 3 the children in treatment A
go to a school in the vicinity of Heideheuvel Children of
treatment B continue to receive schooling at a study
centre at Heideheuvel when they are there for their
biweekly return visit, when they are home they go back
to the school in their own neighborhood. Around week
22 the children in treatment A return to their families
once for a maximum of 1 week. This is to practice the
learned skills at home during a normal week and see
which problems are encountered in their home environ-
ment. After this family leave the encountered problems
are discussed and if necessary plans are adjusted before
the children are going back home again.
Phase 4 (weeks 27-52 for treatment A as well as for
treatment B)
In the fourth phase, the maintenance phase, the children
live at home again and go to their own school. During
this period, which is aimed at preserving the acquired
skills and maintaining the new body weight, there are
monthly 2-day return visits for the children. During the
second day of the return visits the parents also take part
in the treatment. Each return visit a different topic
related to the treatment is being discussed with the chil-
dren in sessions both with and without the parents
attending. The topics discussed are: autonomy, the
family, dealing with emotions, my body, self confidence
and self image. The topics also help to look ahead and
plan how to tackle possible problems in the future. Dur-
ing these return visits also problems encountered at
home are discussed and used as educational examples.
Table 1 describes for both treatments in detail the
number of appointments the children have with differ-
ent professionals of the multidisciplinary team in differ-
ent phases of the treatment. In addition to the contacts
described in the table, two group coaches are always
present during the day to provide ongoing learning and
education. They can support the children in the learned
behavior and observe the children and discuss possible
difficulties. During the night there is always supervision
of a night nurse. For more information on the different
disciplines involved see Table 2.
Measurements
Primary outcome measure is (SDS) BMI. Secondary out-
comes are quality of life and cardiovascular risk factors
like blood pressure, bodily circumferences, serum lipids,
glucose levels and insulin levels. Eating behavior and
physical activity are also assessed. The EuroQoL (EQ-
5D) is used to measure quality of life and to calculate
Quality Adjusted Life Years (QALYs) over the follow-up
period of 24 months. Measurements will be done at
four points in time: at baseline (start of treatment) and
after 6, 12 and 24 months.
Height, weight and circumferences
Height is recorded with a Holtain stadiometer fixed on
the wall with an accuracy of 1 mm. The stadiometer is
calibrated before every first measurement. Height is
recorded three times of which the average is calculated.
Weight is measured in light clothing without shoes and
recorded with a calibrated SECA digital weight chair
that has a limit of 230 kg and an accuracy of 0.005 kg.
Weight and height are used to calculate BMI (weight
in kilograms divided by the square of height in meters).
The degree of overweight is quantified using Cole’s least
mean square method, which normalizes the BMI’s
skewed distribution and expresses BMI as SDS-BMI
Makkes et al. BMC Public Health 2011, 11:518
http://www.biomedcentral.com/1471-2458/11/518
Page 4 of 9
[19]. These calculations are performed using (http://
www.growthanalyser.org; version 3.5, program by
“Stichting Kind en Groei”, downloaded in July 2010).
The data from the fourth Dutch growth study among
children of 1997 are used as reference. The SDS-BMI
indicates how many standard deviations a measurement
is above or below the median of the distribution. Cir-
cumferences of the neck, waist, abdomen (WHO as well
as maximum) and hip are measured with a tape mea-
sure. The participant has to stand up straight (in
Table 1 Details of treatment programs A and B in respect to visits to different health care professionals and treatment
activities
Treatment
A
Treatment
B
Disciplines/treatment
parts
Phase 1
(weeks
1-6)
Phase 2
(weeks
7-18)
Phase 3
(weeks
19-26)
Phase 4
(weeks
26-52)*
Phase 1
(weeks
1-8)
Phase 2 (weeks 10,
12, 14, 16, 18),
n = per visit
Phase 3 (weeks
20, 22, 24, 26),
n = per visit
Phase 4
(weeks
26-52)
Exercise therapist 4G 4G 3G 2G 3G 2G 2G 2G
Cesar therapist 1G 1G 1G 1G (from
week 3 on)
- Once this phase G
Dietician 1I, 1G 1I, 1G 1I, 1G Once this
phase
Twice I in
first 2
weeks
- - Once this
phase
Pediatrician Every other
week 1I
Every other
week 1I
Every other
week 1I
- Every other
week 1I
- Once this phase I -
Psychologist 2I this
phase
Once this
phase I 1G
education
1G
education
- 2I this
phase
Once (children and
parents) this phase
G
Once this phase I -
Nurse Twice this
phase I
Twice this
phase I
- - - - - -
Laboratory Once I this
phase
- Once I this
phase
Once I
this phase
Once I this
phase
- Once I this phase Once I
this
phase
Social worker
(parents)
1G, 2I this
phase
1G 1G 1G 1G 1G 1G 1G
Parents course
(parents)
Twice this
phase G
3 times this
phase G
Once this
phase G
- 8 times this
phase G
Twice this phase G - -
TTV - - Once this
phase I, max
1 week
- - - - -
Education/group-
activity children
- - - 1G 2 to 4G 2 to 4G 2 to 4G 3G
Education/group
activity/training
parents and children
- - - 1G 1G 6 times this phase G 5 times this phase
G
2G
G = group session.
I = Individual session.
Table 2 Explanation of different disciplines and treatment parts
Disciplines/treatment parts Explanation of disciplines/treatment parts
Parents course (parents) A course of several meetings for the parents in which different topics related to the treatment are being
discussed under supervision of the social worker, such as making choices or handling temptations.
TTV Temporarily therapy leave. A period with a maximum of 1 week in which the children of treatment A go
home during the inpatient period to practice learned behavior in a normal setting during weekdays.
Education/group-activity children Several topics related to the treatment are being discussed with the children under supervision of the
group coaches such as motivation, bullying and self image
Activities with the children are supervised by the group coaches. This can be something active like sport
games or something to put an educational topic into practice.
Education/group activity/training
parents and children
The educational sessions for both children and the parents together are always supervised by the group
coaches and a social worker. Several topics related to the treatment are being discussed and occasionally
the pediatrician or psychologist or dietician visits the session to discuss a certain topic.
Activities with the children and their parents supervised by the group coaches and social worker. This
can be something active like sport games or something to put an educational topic into practice.
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underwear) with the arms alongside the body and the
feet in resting position. The circumferences are mea-
sured with an accuracy of 1 mm.
Blood pressure
Blood pressure is measured with a digital blood pressure
monitor (Heine, type Gamma E60). A cuff size with a
width of two-third of the upper arm length is used that
completely covers the arm circumference. For most parti-
cipants a 17 cm cuff size (CAO2, arm circumference 33-
41 cm) is used. If necessary, a 14 cm cuff size (CAO1,
arm circumference 22 32 cm) is used. Blood pressure is
measured in sitting position after sitting still for at least 5
minutes. Blood pressure is measured three times. For the
analyses, the averages of the three systolic blood pressure
and diastolic blood pressure readings are used.
Bio-electrical impedance spectroscopy
Bio-electrical impedance spectroscopy (BIS) measure-
ments are conducted with a Body Impedance Analyzer
BIA 101/s (Akern-SRL Systems by EQUIP Medikey BV).
Two current electrodes (tetra-polar electrodes (3 M red
Dot AG/AgCl)) are placed at the dorsal surfaces of the
hand and foot on the distal portion of the second meta-
carpal and metatarsal, respectively. Two detector electro-
des are placed at the posterior wrist between the styloid
processes of the radius and ulna and at the anterior ankle
between the tibial and fibular malleoli. The resistance
(Ohm) is used in the analysis to determine fat mass (FM)
and fat free mass (FFM). The equation used for the chil-
dren and adolescents in this study for percentage body
fat (%BF) is the adjusted Kushner equation {Wt-[0.59
(Ht2/R)+0.065(Wt)+0.04]/[0.754(Wt)]} x 100 [20]. This
equation is adjusted and validated by Newton et al [21].
Blood measurements
After an overnight fast, blood samples are obtained to
measure lipid spectrum (cholesterol, HDL-cholesterol,
LDL-cholesterol, triglycerides) liver function (y-GT,
ALAT, ASAT) and C-reactive protein (CRP), haemoglo-
bin, hematocrite, MCV, ferritin and HbA1C. In patients
with a triglyceride level ≤ 4.5 mmol/l, LDL-cholesterol is
calculated using the formula of Friedewald. Since this cal-
culation is unreliable in patients with a triglyceride level >
4.5 mmol/l, LDL-cholesterol is measured directly in these
patients using a Roche Cobas 6000 chemical analyzer. The
method for this direct measurement is an enzymatic reac-
tion with the transformation of LDL-cholesterol in a color
product. High sensitive CRP measurement is performed
turbidimetrically with a Roche Cobas 6000 chemical analy-
zer. To determine glucose tolerance and insulin resistance,
the participants are given glucose, in a dose of 1.75 g per
kilogram of body weight (up to a maximum of 75 g) orally.
Blood samples are obtained at 0 and 120 minutes for the
measurement of glucose and insulin levels. In accordance
with the American Diabetes Association guidelines,
impaired fasting glucose is defined as a fasting plasma glu-
cose level between 5.6 - 6.9 mmol/l and impaired glucose
tolerance as a 2-h postload glucose level in the oral glu-
cose tolerance test (OGTT) between 7.8-11.0 mmol/l. Dia-
betes is defined as a fasting plasma glucose level of ≥ 7.0
mmol/l or a 2-h postload glucose level in the OGTT of ≥
11.1 mmol/l [22].
Quality of life
Quality of life is measured using the EQ-5D [23]. The EQ-
5D questionnaire contains a descriptive system of health
related quality of life consisting of five dimensions (mobi-
lity, self-care, usual activities, pain/discomfort, and anxi-
ety/depression). For each dimension there are three levels
of severity (no problems/some or moderate problems/
extreme problems). A standard vertical 20 cm visual ana-
logue scale is also included to measure an individual’s
direct valuation of their current health-related quality of
life state. Utilities will be estimated using the Dutch tariff
[24]. Quality Adjusted Life Years (QALYs) will be calcu-
lated by multiplying the utilities with the amount of time a
participant spent in a particular health state. Transitions
between health states will be linearly interpolated.
Cost measures
Cost calculations will be based on actual resource use,
using prospective data collection during 2 years (the 12
months intervention period and the 12 months follow-
up) through cost diaries. The costs of the interventions
(inpatient care and recurrent return visits of 2 days) will
be estimated using a bottom-up approach. Other costs
include direct healthcare costs (e.g. costs of visits to the
general practitioner, internist, physiotherapist, inpatient
period), direct non-healthcare costs (informal care pro-
vided by parents and legal guardians and travel costs),
and indirect costs (costs related to loss of productivity of
the parents and legal guardians). Cost diaries are for-
matted as calendars on which health care utilization can
be registered. The calendars will be sent to the families
every 3 months. After 3 months the calendars will be
returned by the parents, using stamped envelopes, also if
there has been no health care utilization during that per-
iod. In case a calendar is not returned, use of health care
will be inventoried by telephone calls and/or e-mails.
If available, standard costs recommended by the
Dutch Health Insurance Council will be used to value
resource use [25]. Medication costs will be valued using
prices of the Royal Dutch Society of Pharmacy [26].
Sample size calculation
Based on a previous study comparing intensive inpatient
treatment with an ambulatory treatment in the same
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treatment centre it is calculated that 40 participants in
both intervention groups are sufficient to detect a 0.5
SDS-BMI difference between the two groups after one
year (with a = 0.05 and power = 0.8). Based on earlier
experience in the same setting and with similar partici-
pants it is feasible to recruit these numbers of
participants.
Statistical analyses
An intention-to-treat analysis will be performed. A per
protocol analysis will also be performed after careful
description of correlates of non-adherence and dropout.
To take into account the repeated measurements over
time, we will use generalized estimating equations for
panel data analysis, also known as cross-sectional time-
series analysis, with the use of the Stata software XTGEE
command; this will allow us to account for the non-inde-
pendence of repeated measurements of the same bio-
indicator in the same participant over time. Linear
regression will be applied for continuous outcomes and
logistic regression for dichotomous outcomes. We will
use age, sex, time point, and intervention group as expla-
natory variables in our models.
An economic evaluation from a societal perspective
will be conducted alongside the randomized controlled
trial. Multiple imputation will be used to impute missing
cost and effect data. Five imputed data sets will be cre-
ated, each of which will be analyzed separately. The
results of these five analyses will be pooled using
Rubin’s rules [27].
Costs generally have a highly skewed distribution.
Therefore, bootstrapping with 5000 replications will be
used to estimate “approximate bootstrap confidence”
(ABC) intervals around cost differences [28,29]. Incre-
mental cost-effectiveness and cost-utility ratios will be
calculated by dividing the difference in total costs
between the groups by the difference in SDS-BMI and
QALYs, respectively. Non-parametric bootstrapping will
also be used to estimate the uncertainty surrounding the
incremental cost-effectiveness and cost-utility ratios
(5000 replications). The bootstrapped cost-effect pairs
will be plotted on a cost-effectiveness plane (CE plane)
[30] and used to estimate cost-effectiveness acceptability
curves (CEA curves). CEA curves show the probability
that the intervention is cost-effective in comparison
with usual care for a range of ceiling ratios. The ceiling
ratio is defined as the amount of money society is will-
ing to pay to gain one unit of effect [31].
Discussion
This paper presents the design of a randomized con-
trolled trial comparing the cost effectiveness of two
intensive one-year inpatient treatments to each other
and to usual care for severely obese children and
adolescents. The study will not only provide insight in
the effects of 1 year treatment, but also the maintenance
one year after the end of the treatment. Studies regard-
ing the effectiveness and cost-effectiveness of treatment
programs (with or without an inpatient period) for
obese children and adolescents are relatively rare, espe-
cially for the severely obese [13]. Kelly and Kirschen-
baum reviewed published studies on inpatient treatment
for childhood and adolescent obesity [12]. Their review
showed that programs containing an inpatient period
had better weight loss and subsequent weight mainte-
nance compared to the outpatient treatments. The rates
of attrition were also lower in the inpatient treatment
groups. Our study can add important knowledge on the
usefulness of inpatient treatment in severely obese chil-
dren and adolescents.
An important strength of this study is the randomized
controlled trial design. Another strength is that both
young children (8-13 years of age) and adolescents (13-
18 years of age) will be included in this study, since obe-
sity is an important health problem in these age groups.
This study provides information on the effectiveness
and feasibility of the intervention in both age groups
that differ in environmental and individual factors asso-
ciated with obesity, such as the role of the parents and
peers. Also participants of different ethnic groups and
from rural and urban areas from different parts in the
Netherlands will participate in the study. This will con-
tribute to the generalizability of the outcomes to the
general population of severely obese children and ado-
lescents in the Netherlands. Moreover this study will
provide information on the feasibility to implement the
program on a larger scale and perhaps also in other set-
tings such as regular hospitals.
A challenge of the study will be keeping the attrition
rate to a minimum. The study population is expected to
have a relatively low socioeconomic status (SES) and to
present relatively many psychological problems and
socially complicated family structures. This can interfere
with adherence to the treatment program. The psycholo-
gical characteristics of the patients and their parents will
be described in a separate study. Another difficulty will
be the recruitment of participants, because of the
extended inpatient periods. Especially in the group of
children aged 8-13, we expect problems with recruitment
because an inpatient period of 2 or 6 months imposes a
very heavy burden on families and children. Also,
because recruitment is nationwide, part of the parents
will have to travel quite a lot, since their active participa-
tion and frequent presence during treatment is required.
This can lead to high work absenteeism for the parents
or loss of vacation days which will also be measured.
For the calculation of %BF the adjusted equation by
Kushner et al is used [20], since the original equation by
Makkes et al. BMC Public Health 2011, 11:518
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Kushner et al is developed to calculate total body water
and is therefore not applicable. We have chosen for this
equation after careful consideration as there are more
suitable equations to calculate %BF specifically devel-
oped for obese children and adolescents such as the
equations of Lazzer et al [32] and Schaeffer et al[33].
However we are limited in our choice because only
resistance (R) is recorded. Cost calculations will be
based on actual resource use; therefore prospective data
collection through cost diaries during 2 years is used.
However, the risk of this type of data collection is drop
out; the longer the participant are followed, the higher
the chance of loss to follow up. Also, bias can be intro-
duced with this type of data collection, since it is based
on self reporting. People can forget to note absenteeism
or visits to health care professionals, even with the use
of the cost diaries. By prospectively collecting data we
hope to get valid estimates of health care utilization.
The major cost savings as a result of treatment are
expected to come about much later in the lives of these
children, the effects on productivity, absenteeism, dis-
ease incidence and use of medical care potentially may
have an effect after decades. To be able to predict such
cost savings, this short term cost-effectiveness analysis is
too limited because this study is based on actual
resource use, using the actual costs of the interventions,
direct healthcare costs, direct non-healthcare costs and
indirect costs for the period of 2 years. In the long term
the cost savings will be much higher than in this short
term of 2 years, therefore these interventions are invest-
ments in the long term. To make models to predict
these long term cost savings is risky, because the long
term effects of such interventions are not known.
Despite the challenges mentioned above, the results of
the study will offer valuable information to health care
professionals as well as policy makers regarding treat-
ment of severely obese children and adolescents.
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